07:45:21 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



News for C:FRX from 2023-03-30 to 2024-03-29 - 24 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-03-21 09:50C:FRXFennec Pharmaceuticals Inc13.18News ReleaseFennec loses $16.04-million (U.S.) in 2023
2024-03-19 09:27C:FRXFennec Pharmaceuticals Inc13.18News ReleaseFennec to release fiscal 2023 results March 21
2024-03-18 02:32C:FRXFennec Pharmaceuticals Inc13.18News ReleaseFennec enters Pedmarqsi licensing deal with Norgine
2024-02-29 12:24C:FRXFennec Pharmaceuticals Inc12.89News ReleaseFennec expects revenue of $20.7M to $21.2M for 2023
2024-02-01 09:29C:FRXFennec Pharmaceuticals IncNews ReleaseFennec notes FDA reminder re Pedmark non-substitution
2023-12-05 09:27C:FRXFennec Pharmaceuticals Inc12.55News ReleaseFennec closes $5-million investment from Petrichor
2023-11-10 17:44C:FRXFennec Pharmaceuticals Inc10.75SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-10 17:43C:FRXFennec Pharmaceuticals Inc10.75SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-06 11:15C:FRXFennec Pharmaceuticals Inc10.96News ReleaseFennec loses $1.86-million (U.S.) in Q3 2023
2023-10-30 12:26C:FRXFennec Pharmaceuticals Inc9.64News ReleaseFennec Pharmaceuticals to release Q3 results Nov. 6
2023-08-08 14:47C:FRXFennec Pharmaceuticals Inc10.63SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-03 09:59C:FRXFennec Pharmaceuticals Inc10.63News ReleaseFennec Pharmaceuticals loses $5.44-million (U.S.) in Q2
2023-07-31 12:59C:FRXFennec Pharmaceuticals Inc11.27News ReleaseFennec Pharmaceuticals to release Q2 results Aug. 3
2023-06-12 17:16C:FRXFennec Pharmaceuticals Inc11.65News ReleaseFennec Pharmaceuticals holders approve AGM resolutions
2023-06-06 09:44C:FRXFennec Pharmaceuticals Inc11.51News ReleaseFennec receives Pedmarqsi marketing OK by EU Commission
2023-06-01 13:35C:FRXFennec Pharmaceuticals Inc10.25SEDAR MD & ASEDAR MD & A
2023-06-01 13:29C:FRXFennec Pharmaceuticals Inc10.25SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-05-11 10:00C:FRXFennec Pharmaceuticals Inc10.67News ReleaseFennec Pharmaceuticals loses $6.05-million (U.S.) in Q1
2023-05-08 11:37C:FRXFennec Pharmaceuticals Inc10.98News ReleaseFennec to release Q1 2023 results May 11
2023-03-31 13:08C:FRXFennec Pharmaceuticals Inc11.20SEDAR Annual ReportSEDAR Annual Report
2023-03-31 13:07C:FRXFennec Pharmaceuticals Inc11.20SEDAR MD & ASEDAR MD & A
2023-03-31 13:05C:FRXFennec Pharmaceuticals Inc11.20SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-03-31 09:12C:FRXFennec Pharmaceuticals Inc11.00News ReleaseFennec receives European marketing OK for Pedmarqsi
2023-03-30 09:49C:FRXFennec Pharmaceuticals Inc11.20News ReleaseFennec loses $23.71-million (U.S.) in fiscal 2022